Menu
Back to Journals » Biologics: Targets and Therapy » Volume 16
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (502)
- Volume 18, 2024 (6)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 16, 2022
Adherence to Subcutaneous Anti-Tumour Necrosis Factor Treatment in a Cohort of Patients with Rheumatoid Arthritis Before and After the Implementation of a Comprehensive Care Model
Santos-Moreno P, Sánchez-Vanegas G, Monterrosa-Blanco A, Rodríguez-Vargas GS, Rivero M, Rodriguez P, Calixto OJ, Rojas-Villarraga A, Castro CA
Biologics: Targets and Therapy 2022, 16:199-209
Published Date: 21 November 2022
TNF Inhibitors Exert a “Hidden” Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients
Calvo Alén J, Lavin-Gomez BA, Aurrecoechea E, Guerra Ruiz AR, Martínez Taboada V, Gómez Gerique J
Biologics: Targets and Therapy 2022, 16:187-197
Published Date: 17 October 2022
Phage Therapy: A Different Approach to Fight Bacterial Infections
Hibstu Z, Belew H, Akelew Y, Mengist HM
Biologics: Targets and Therapy 2022, 16:173-186
Published Date: 6 October 2022
Biosimilars: Science, Implications, and Potential Outlooks in the Middle East and Africa
Batran RA, Elmoshneb M, Hussein AS, Hussien OM, Adel F, Elgarhy R, Morsi MI
Biologics: Targets and Therapy 2022, 16:161-171
Published Date: 6 October 2022
Emerging Therapies for Huntington’s Disease – Focus on N-Terminal Huntingtin and Huntingtin Exon 1
van der Bent ML, Evers MM, Vallès A
Biologics: Targets and Therapy 2022, 16:141-160
Published Date: 30 September 2022
A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances
Abdulla M, Mohammed N
Biologics: Targets and Therapy 2022, 16:129-140
Published Date: 12 September 2022
Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
Alorfi NM, Alourfi MM
Biologics: Targets and Therapy 2022, 16:119-127
Published Date: 5 August 2022
Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population
Santos-Moreno P, Martinez S, Ibata L, Villarreal L, Rodríguez-Florido F, Rivero M, Rojas-Villarraga A, Galarza-Maldonado C
Biologics: Targets and Therapy 2022, 16:107-117
Published Date: 13 July 2022
Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review
Kandula UR, Wake AD
Biologics: Targets and Therapy 2022, 16:89-105
Published Date: 8 July 2022
Successful Treatment of an Adult with Atopic Dermatitis and Lamellar Ichthyosis Using Dupilumab
Binkhonain FK, Aldokhayel S, BinJadeed H, Madani A
Biologics: Targets and Therapy 2022, 16:85-88
Published Date: 23 June 2022
Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician
Saleh A, Ansari U, Abughazaleh S, Glassner K, Abraham BP
Biologics: Targets and Therapy 2022, 16:67-83
Published Date: 17 June 2022
Biosimilars in Pediatric IBD: Updated Considerations for Disease Management
Dipasquale V, Cucinotta U, Romano C
Biologics: Targets and Therapy 2022, 16:57-66
Published Date: 13 June 2022
Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis
Mykoniatis I, Tsiakaras S, Samarinas M, Anastasiadis A, Symeonidis EN, Sountoulides P
Biologics: Targets and Therapy 2022, 16:47-55
Published Date: 20 May 2022
Targeting Metabolic Reprogramming of T-Cells for Enhanced Anti-Tumor Response
Dabi YT, Andualem H, Degechisa ST, Gizaw ST
Biologics: Targets and Therapy 2022, 16:35-45
Published Date: 9 May 2022
Progress in Biological Therapies for Adult-Onset Still’s Disease
Galozzi P, Bindoli S, Doria A, Sfriso P
Biologics: Targets and Therapy 2022, 16:21-34
Published Date: 21 April 2022
Continuous Use of Etanercept During Pregnancy Does Not Affect TNF-Alpha Levels in Umbilical Cord Blood
Nishide M, Yagita M, Kumanogoh A
Biologics: Targets and Therapy 2022, 16:17-19
Published Date: 31 March 2022
A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon
Temraz S, Nasr F, Kattan J, Abigerges D, Moukadem W, Farhat F, Maatouk L, Chahine G, Shamseddine A
Biologics: Targets and Therapy 2022, 16:7-15
Published Date: 21 February 2022
Efficacy of Anti-Tumor Necrosis Factor-α Therapy Against Intestinal Behçet’s Disease Complicated by Recurrent Enterocutaneous Fistulae
Kashima H, Matsumoto S, Kojima S, Koito Y, Miura T, Ishii T, Mashima H
Biologics: Targets and Therapy 2022, 16:1-6
Published Date: 2 February 2022